Gastroenterology Research and Practice
Volume 2021 (2021), Article ID 9823426, 1 page
https://doi.org/10.1155/2021/9823426

Corrigendum

Corrigendum to “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori”

Lingyun Zhang, Yu Lan, Qi Wang, Yuexia Zhang, and Xiaobei Si

Department of Gastroenterology, Beijing Jishuitan Hospital, NO 68, Hui Nan Road, Changping District, Beijing 100096, China

Correspondence should be addressed to Yu Lan; 13621014609@163.com

Received 10 May 2021; Accepted 10 May 2021; Published 25 May 2021

Copyright © 2021 Lingyun Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori” [1], there was an error in Subjects and Methods. This error is shown below:

“(Wyeth-Palace Pharmaceutical Co., Ltd, 1.0g, BID)” should read “(Wyeth-Palace Pharmaceutical Co., Ltd, 0.1 g, BID).”

References

L. Zhang, L. Yu, Q. Wang, Y. Zhang, and X. Si, “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori,” Gastroenterology Research and Practice, vol. 2019, Article ID 9251879, 6 pages, 2019.